Work

Twelve-week Monotherapy with the DPP-4 Inhibitor Vildagliptin Improves Glycemic Control in Subjects with Type 2 Diabetes

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Hormone and Metabolic Research

DOI: 10.1055/s-2006-944546

Authors: R. Pratley, S. Jauffret-Kamel, E. Galbreath, D. Holmes

Institutions: University of Vermont, University of Vermont Medical Center, Novartis (Switzerland)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2167621077

FWCI: 24

Cites: 17

Cited by: 191

Related to: 10